Impact BioMedical, Inc.

IBOAMEX • USD
ThemeBiotech - Drug Development›Neuroscience & CNS
0.55 USD
↗ 0.01 (2.31%)🟢LIVE (AS OF 02:52 PM EDT)
🟢Market: OPEN
Open?$0.54
High?$0.56
Low?$0.53
Prev. Close?$0.54
Volume?14.8K
Avg. Volume?100.9K
VWAP?$0.54
Rel. Volume?0.15x
Bid / Ask
Bid?$0.54 × 200
Ask?$0.56 × 500
Spread?$0.03
Midpoint?$0.55
Valuation & Ratios
Market Cap?58.2M
Shares Out?107.8M
Float?1.3M
Float %?10.9%
P/E Ratio?N/A
P/B Ratio?5.08
EPS?-$0.12
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.
Themes
Biotech - Drug Development›Neuroscience & CNSHealthcare - Oncology›Immunotherapy & Immuno-OncologyBiotech - Drug Development›Infectious Disease & Vaccines
Employees
8
Market Cap
58.0M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.impactbiomedinc.com
Listed
2024-09-16
Address
1400 BROADFIELD BLVD.
HOUSTON, TX 77084
Phone: 585 232 1500
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?0.22Weak
Quick Ratio?0.19Weak
Cash Ratio?0.01Low
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score
58/100
P/E?
N/A▾
P/B?
5.08FAIR▾
P/S?
1,492.91HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
-13.2CHEAP▾
EV/Sales?
1,492.40HIGH▾
Returns & Efficiency
ROE?
-112.2%WEAK▾
ROA?
-75.3%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$58.2M
Fundamentals ratios updated end of day
MarketsMoversWatchlist